MMI Receives FDA IDE Approval for First Robotic Microsurgical Study Targeting Alzheimer’s Disease

06 November 2025 | News

The REMIND study will evaluate the safety and effectiveness of the Symani® Surgical System for restoring lymphatic drainage pathways in Alzheimer’s patients.

Subscribe to our newsletter

Monthly digest of what's new and exciting from us.

We'll never share your email with anyone else.

Most Read